Showing results (1191-1200 of 1,878) with videos related to

Sort By:
Pageof 188
Immunotherapy|July 19, 2023
Pembrolizumab plus chemotherapy for advanced non-small-cell lung cancer without tumor PD-L1 expression in AsiaYing Cheng, James Chih-Hsin Yang, Isamu Okamoto, et al.
Immunotherapy|July 11, 2023
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemicGordon Taylor Moffat, Lilian Hanna, Wilma Hopman, et al.
Immunotherapy|July 4, 2023
Cost-effectiveness analysis of serplulimab as first-line treatment for advanced esophageal squamous cell carcinomaZhiwei Zheng, Ling Fang, Hongfu Cai, et al.
Immunotherapy|July 4, 2023
Prolonged clinical remission of type 1 diabetes sustained by calcifediol and low-dose basal insulin: a case reportMarco Infante, Laura Vitiello, Andrea Fabbri, et al.
Immunotherapy|January 30, 2019
Intestinal microbiota predicts lung cancer patients at risk of immune-related diarrheaTian Liu, Qi Xiong, Lingling Li, et al.
Immunotherapy|February 8, 2019
Heat-shock proteins in diagnosis and treatment: an overview of different biochemical and immunological functionsAlireza Milani, Marzieh Basirnejad, Azam Bolhassani
Immunotherapy|January 31, 2019
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of actionNi Zhang, Jingyao Tu, Xue Wang, et al.
Immunotherapy|September 9, 2020
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulinsJosé María Díez, Carolina Romero, Júlia Vergara-Alert, et al.
Immunotherapy|March 17, 2020
Successful treatment of metastatic colorectal cancer with synchronous BRAF V600E mutation and dMMR with BGB-A317Yi Cheng, Xue-Feng Fang, Han-Guang Hu, et al.
Immunotherapy|September 22, 2020
Omalizumab and adalimumab: a winning coupleLaura Diluvio, Laura Vollono, Arianna Zangrilli, et al.
Pageof 188